Described almost two decades ago as a Ras-GTP binding protein, RASSF1A is one of the prototypical tumor-suppressor genes frequently inactivated in >40 types of human malignancies, including lung, breast, prostate, glioma, neuroblastoma, multiple myeloma, and kidney cancer1–3. The gene discussed is RASSF1; the disease is neoplasm.